Skip to main content
OpenTrials
Completed

NCT Number: NCT05186831

Patient-Portal vs Text-based Hypertension Monitoring Among Black Medicaid/Medicare Patients

The coronavirus disease 2019 (COVID-19) pandemic has uprooted conventional health care delivery for routine ambulatory care, requiring health systems to rapidly adopt telemedicine capabilities. The digital divide, has been well documented with lower rates of technology and broadband adoption among racial/ethnic minorities. Additionally, Black patients suffer a disproportionate burden of hypertension and cardiovascular disease. This study will implement a text-based home hypertension monitoring program among Black Medicaid patients with hypertension and cardiovascular disease (CVD) and compare its uptake to the currently available blood pressure monitoring program using the patient portal that is integrated into the electronic health record (EHR).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self-identified Black race
  • Medicaid or Medicare insurance
  • Hypertension
  • Cardiovascular disease or presence of at least 1 cardiovascular risk factor
  • Seen for in-person consultation at the Heart and Vascular clinic at the Hospital of the University of Pennsylvania

Exclusion criteria

  • Does not speak English
  • Already owns a BP cuff
  • Does not have internet access or a phone 15 with texting capabilities

Treatment and study plan

Texting

Behavioral

Patients will be asked to text their BP. They will receive an automated response to their texts.

Online patient portal

Behavioral

Patients will be asked to upload their BP to the online patient portal. They will receive information on how to sign up and use the patient portal. Patients can upload their BP readings daily or at the end of the study period.

Primary outcomes

  1. Number of BP measurements reported

    Time frame: 14 days

    Number of BP results reported over the study period

  2. Proportion of patients submitting 1 or more BP measurement

    Time frame: 14 days

    Proportion of patients per study arm reporting at least one BP measurement

Secondary outcomes

  1. Patient satisfaction

    Time frame: Within 2 weeks of end of study period

    Patients will be asked to complete a survey about ease of use and likelihood of recommending the intervention

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
Jan 11, 2022
Registry last updated
Jan 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.